Rib-X Reports Preclinical Studies at ICAAC with Novel Classes of RX-04 Antibiotic Compounds Demonstrating Potent and Rapid Efficacy in a S.pneumoniae Lung Model of Infection and Activity Against a Diverse Spectrum of Biodefe